Osteolytic bone metastases of breast cancer

Osteolytic bone metastases of breast cancer represent an advanced skeletal complication occurring when malignant breast epithelial cells disseminate to the bone microenvironment This clinical state is characterized by tumor-driven disruption of normal skeletal remodeling, where neoplastic cells secrete cytokines such as parathyroid hormone-related protein (PTHrP) that stimulate osteoblasts to express RANK ligand This pathway induces pathological osteoclastogenesis and excessive bone resorption, ...

Osteolytic bone metastases of breast cancer represent an advanced skeletal complication occurring when malignant breast epithelial cells disseminate to the bone microenvironment The resulting skeletal destruction frequently manifests with intractable bone pain, hypercalcemia of malignancy, pathological fractures, and structural instability such as spinal cord compression

This clinical state is characterized by tumor-driven disruption of normal skeletal remodeling, where neoplastic cells secrete cytokines such as parathyroid hormone-related protein (PTHrP) that stimulate osteoblasts to express RANK ligand This pathway induces pathological osteoclastogenesis and excessive bone resorption, causing localized matrix degradation and osteolytic lesions rather than new bone formation

The resulting skeletal destruction frequently manifests with intractable bone pain, hypercalcemia of malignancy, pathological fractures, and structural instability such as spinal cord compression